AU Patent

AU2010276242B2 — Ferric citrate dosage forms

Assigned to Keryx Biopharmaceuticals Inc · Expires 2014-05-29 · 12y expired

What this patent protects

The disclosure relates to ferric citrate tablets and dosage forms.

USPTO Abstract

The disclosure relates to ferric citrate tablets and dosage forms.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010276242B2
Jurisdiction
AU
Classification
—
Expires
2014-05-29
Drug substance claim
No
Drug product claim
No
Assignee
Keryx Biopharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.